Microchip Technology Inc
MCHP
$67.22
+2.47%
Microchip Technology Inc. is a leading provider of microcontroller (MCU) and analog semiconductors, operating within the broader semiconductor industry. The company has established itself as a dominant player in the lower-end 8-bit MCU market, which is embedded in a vast array of everyday electronic devices, while also expanding its portfolio into higher-performance MCUs and analog chips. The current investor narrative is focused on the company's cyclical recovery trajectory, as evidenced by a return to revenue growth and profitability in its most recent quarter after a period of significant contraction, with debates centering on the sustainability of this rebound amidst ongoing inventory normalization and macroeconomic headwinds in the semiconductor sector.…
MCHP
Microchip Technology Inc
$67.22
MCHP 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Microchip Technology Inc's 12-month outlook, with a consensus price target around $87.39 and implied upside of +30.0% versus the current price.
Average Target
$87.39
3 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
3
covering this stock
Price Range
$54 - $87
Analyst target range
Analyst coverage for Microchip appears limited in the provided dataset, with only 3 analysts contributing to the estimated EPS average of $3.84 for the upcoming period. This suggests the stock may have less widespread institutional coverage than some mega-cap peers, which can lead to higher volatility and less efficient price discovery. The consensus, inferred from the limited data and recent institutional rating actions, leans bullish, with firms like JP Morgan (Overweight), Citigroup (Buy), Mizuho (Outperform), and Needham (Buy) maintaining positive ratings, while others like Wells Fargo and Truist Securities hold neutral (Equal Weight/Hold) stances. The target price range is not explicitly provided in the data, but the estimated EPS range of $3.56 to $4.29 implies a significant variance in earnings expectations, translating to a wide potential target price range. The high-end EPS estimate of $4.29 likely assumes a robust cyclical recovery with strong margin leverage, while the low-end of $3.56 may price in a more muted rebound or ongoing macroeconomic challenges. The recent institutional rating actions in February 2026 were all reiterations, indicating analysts are in a 'wait-and-see' mode, confirming their existing theses post-earnings rather than signaling a major shift in sentiment.
MCHP Technical Analysis
The stock is in a pronounced recovery phase from a deep trough, having posted a significant 34.07% gain over the past year. However, the current price of $65.60 sits at approximately 78.7% of its 52-week range ($34.13 to $83.35), indicating it has recovered substantially from its lows but remains meaningfully below its recent peak, suggesting the rally may be maturing and facing resistance. Recent momentum has turned negative, with the stock declining 8.11% over the past month, which starkly contrasts with its strong 1-year performance and signals a potential short-term consolidation or pullback. This divergence is further highlighted by the stock's 3-month gain of only 0.88%, significantly underperforming the S&P 500's 4.0% decline over the same period, indicating relative strength is waning after a sharp run-up earlier in the year. Key technical support is anchored at the 52-week low of $34.13, though a more relevant near-term floor may be found around the $60-$62 level where the stock recently found footing. Immediate resistance is at the 52-week high of $83.35, a level that represents substantial upside but also a formidable barrier given the recent retreat from the $80 area. A sustained breakout above $83.35 would signal a resumption of the primary bull trend, while a breakdown below the $60 support could indicate a deeper correction is underway. The stock's beta of 1.474 confirms it is approximately 47% more volatile than the broader market, which amplifies both upside and downside moves and is a critical factor for risk-aware investors.
Beta
1.47
1.47x market volatility
Max Drawdown
-40.9%
Largest decline past year
52-Week Range
$34-$83
Price range past year
Annual Return
+85.6%
Cumulative gain past year
| Period | MCHP Return | S&P 500 |
|---|---|---|
| 1m | +3.8% | -2.0% |
| 3m | -10.2% | -4.8% |
| 6m | +0.4% | -2.1% |
| 1y | +85.6% | +30.4% |
| ytd | +3.4% | -3.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MCHP Fundamental Analysis
Revenue has demonstrated a clear recovery trajectory, with the most recent quarterly revenue reaching $1.186 billion, representing a 15.59% year-over-year increase. This growth marks a significant turnaround from the prior quarters of decline, as revenue sequentially improved from $970.5 million in Q4 2025 to $1.186 billion in Q3 2026. The semiconductor products segment, constituting $1.127 billion of the total, is the primary growth driver, indicating core demand is rebounding. This accelerating growth trend is a positive signal that the company is emerging from the cyclical downturn that impacted its financials in early 2025. Profitability has returned but remains under pressure. The company reported net income of $34.9 million for Q3 2026, a sharp improvement from a net loss of $154.6 million in Q4 2025. Gross margin expanded significantly to 59.6% in the latest quarter, up from 51.6% in Q4 2025 and 41.2% in Q2 2026, reflecting better pricing and product mix. However, operating margin stands at 12.79%, which, while positive, indicates that operating expenses remain elevated relative to the revenue base, leaving room for further efficiency gains as the recovery solidifies. The balance sheet shows moderate leverage with a debt-to-equity ratio of 0.80, which is manageable for the industry. Financial health is supported by robust free cash flow generation, with TTM free cash flow of $819.9 million. The current ratio of 2.59 indicates strong short-term liquidity. Return on equity (ROE) is currently negligible at -0.00007, and return on assets (ROA) is a low 1.16%, reflecting the recent period of depressed earnings, but the positive net income and cash flow suggest these metrics are poised for improvement as profitability normalizes.
Quarterly Revenue
$1.2B
2025-12
Revenue YoY Growth
+0.15%
YoY Comparison
Gross Margin
+0.59%
Latest Quarter
Free Cash Flow
$819900000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MCHP Overvalued?
Given the company's return to profitability with positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE ratio is an extreme -52,021x due to legacy losses, but the forward PE of 24.7x is the relevant figure, indicating the market is pricing in a normalized earnings stream. The significant gap between the negative trailing and positive forward multiple underscores the market's expectation of a sharp earnings recovery from the cyclical trough. Compared to sector averages, Microchip trades at a premium based on its forward PE of 24.7x, though a precise industry average PE is not provided in the data. Its Price-to-Sales (PS) ratio of 5.91x and EV/Sales of 9.30x are also elevated, suggesting the market is assigning a higher multiple in anticipation of sustained growth and margin expansion. This premium is likely justified if the company can continue to execute on its recovery and deliver on the projected earnings growth implied by the forward multiple. Historically, the stock's current forward PE of 24.7x sits well below its own historical peaks seen in recent years, such as the PE of 137.4x in Q2 2025 and 95.0x in Q1 2025. This indicates that while the stock has rallied, its valuation on an earnings basis is not stretched relative to its own history, potentially leaving room for multiple expansion if the earnings recovery proves durable and exceeds current expectations.
PE
-52021.4x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -510x~246x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
29.7x
Enterprise Value Multiple

